An example of this is HL2401, a monoclonal antibody anti-human CXCL1 [44] which inhibits the proliferation and migration of bladder and prostate cancer cells and inhibits the angiogenesis of the tested tumors. This evidence concerns the gene CXCL1 and prostate cancer.